What a phenomenal Market reaction yesterday and today I believe you will see DXB continue to climb..
It has been brought to my attention that the CEO and Senior Management Team at DXB worked all night , everyone on deck all night to craft the delivery of the Licensing deal to the wider market. "Worked all Night and then completed a flawless webinar" to benefit SH and garnish the market wide attention the Treatment deserved.
Great to have talked with so many last night that are also PAA holders..
What became apparent during discussions last night is that there are only 2 incumbents in the MND Treatment Market/Space
The split in revenue is pretty much 50/50 with the current market revenue of circa $1.2B to each Party/Company.
Now both treatments only add on a few months of life expectancy with considerable adverse effects , so it would seem that MPL Trumps both Treatments hands down.(current data to date)
So which ever of the incumbents takes out the license first with PAA will scoop the other half of the market effectively doubling their company's' return and more than likely eliminating the other Party/Company from the MND Treatment market.
Should PAA actually announce something definitive "and lets be honest ,,To Date they have never been definitive" eliminating bullshit terms like "seems to" "May well" and the death nail for PAA "Requires further testing" and the New CEO has his hands on the reins and is not bridled by the BOD then we should see significant market gains similar to DXB or even greater..
With the Recognition and Reward Options strike date fast approaching a VISUALLY SIGNIFICANT EFFORT needs to be seen by SH that there was any form of strategy to get the Oppies in the money and not just a fast grab for a stop gap from infringing the 2 Quarter of Operating Capital Regulation.
PAA Management over the next three weeks will be under laser focus leading up to the Oppies date / 4c Quarterly onto the AGM....
Shows what can be accomplished when an entire Company place a concerted effort into delivering SH Value and a simple road map for PAA to follow..
My Grandad had a saying
"Just like in the Dictionary , Reward comes after Effort"
So now it's time for PAA SH to see some serious effort in gaining SH Value from the last round of MND Date,,, ohhhh plus where's the Dog Deal??
In fairness here was a definitive announcement on the 9th of September 2020 Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed https://stocknessmonster.com/announcements/paa.asx-6A995129/ But Management decided not to pursue this??
PAA Price at posting:
8.1¢ Sentiment: Buy Disclosure: Held
(20min delay)